𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Metachronous colorectal carcinoma

✍ Scribed by Dr S. Bülow; L. B. Svendsen; A. Mellemgaard


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
395 KB
Volume
77
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

✦ Synopsis


Metachronous colorectal carcinoma

During the period 194347, 903 Danish patients aged <40 years had colorectal carcinoma. The patients were followed up f o r up to 41 years and during this period 44 of 501 ( 9 per cent) operated on f o r cure developed a metachronous colorectal carcinoma. The cumulative risk of a metachronous colorectal carcinoma was 30 per cent after up to 41 years of observation. The occurrence of a metachronous colorectal carcinoma was evenly distributed in the observation period. The cumulative survival rate after operation for a metachronous colorectal carcinoma was 41 per cent after 20 years of observation. W e propose a lifelong follow-up programme after resection of colorectal carcinoma f o r cure in this age group, including annual Hemoccult" test and colonoscopy at 3-year intervals.


📜 SIMILAR VOLUMES


The significance of microsatellite insta
✍ Shigehiko Masubuchi; Fumio Konishi; Kazutomo Togashi; Tomomi Okamoto; Shingo Sen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## BACKGROUND. Patients with metachronous multiple colorectal carcinomas have been reported to have a higher frequency of a family history of colorectal carcinoma, associated colorectal adenomas, and extracolonic malignancies. These clinicopathologic factors also are considered to be related to th

Colorectal carcinoma
✍ A. Wyman; K. Rogers 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB
Colorectal carcinoma survival among here
✍ Patrice Watson; Kevin M. Lin; Miguel A. Rodriguez-Bigas; Tom Smyrk; Stephen Lemo 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

## BACKGROUND. Patients with hereditary nonpolyposis colorectal carcinoma (HNPCC) reportedly have better prognoses than sporadic colorectal carcinoma (CRC) patients, but it has been unclear whether this could be due to differences in stage at diagnosis. The current study compared stage and surviva